关于Efgartigimod治疗对自身免疫性节节病的疗效的初步观察
Hongfei Tai1,2, Songtao Niu1,2, Hua Pan1,2
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
European journal of neurology
|July 10, 2025
概括
在自身免疫性结节病患者中,efgartigimod迅速改善了功能,显示出对这种疾病的希望. 响应因抗体亚型而异,表明需要个性化治疗策略.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自身免疫结节病症在当前免疫疗法方面存在挑战.
- 新生儿Fc受体抑制剂Efgartigimod正在研究其治疗这种疾病的潜力.
研究的目的:
- 评估efgartigimod在患有自身免疫结节病的患者中的疗效和安全性.
- 评估efgartigimod对神经功能和疾病进展的影响.
主要方法:
- 一项前性单中心研究涉及四名抗体确诊的自身免疫结节病患者.
- 患者每周接受efgartigimod (10毫克/公斤) 四周.
- 神经学评估在基线进行,在治疗期间每周一次,并在8周的随访期间进行.
主要成果:
- 所有四名患者在两周的efgartigimod治疗内都显示出功能改善.
- 响应因抗体亚型而异,在一个患者 (anti-NF186 IgG3+) 中完全缓解,在其他患者中部分恢复.
- 在研究期间没有报告任何严重不良事件.
结论:
- 在自身免疫结节病症中,efgartigimod显示出快速功能恢复的潜力.
- 基于IgG亚类和抗原标的差异性反应表明需要生物标志物引导的治疗策略.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275
01:29Autoimmune Disorders
679
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
679